(Q36392523)

English

Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab.

scientific article published on 4 December 2015

Statements

Fibrocyte-like cells mediate acquired resistance to anti-angiogenic therapy with bevacizumab (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit